Literature DB >> 3214094

Liposomes as carriers of antifungal drugs.

G Lopez-Berestein1.   

Abstract

Mesh：

Substances：

Year:  1988        PMID： 3214094     DOI： 10.1111/j.1749-6632.1988.tb40459.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  16 in total

1.  Amphotericin B lipid complex or amphotericin B multiple-dose administration to rabbits with elevated plasma cholesterol levels: pharmacokinetics in plasma and blood, plasma lipoprotein levels, distribution in tissues, and renal toxicities.

Authors:  M Ramaswamy; K D Peteherych; A L Kennedy; K M Wasan
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

2.  Rat and rabbit plasma distribution of free and chylomicron-associated BIRT 377, a novel small molecule antagonist of LFA-1-mediated cell adhesion.

Authors:  K M Wasan; M Ramaswamy; L Holtorf; A A Jayaraj; D J Hauss
Journal:  Pharm Res       Date:  2001-04       Impact factor: 4.200

Review 3.  Diversity of lipid-based polyene formulations and their behavior in biological systems.

Authors:  K M Wasan; G Lopez-Berestein
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-01       Impact factor: 3.267

4.  Amphotericin B incorporated into egg lecithin-bile salt mixed micelles: molecular and cellular aspects relevant to therapeutic efficacy in experimental mycoses.

Authors:  J Brajtburg; S Elberg; G S Kobayashi; J Bolard
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

5.  Evaluation of renal toxicity and antifungal activity of free and liposomal amphotericin B following a single intravenous dose to diabetic rats with systemic candidiasis.

Authors:  K M Wasan; J S Conklin
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

6.  Treatment of murine cryptococcal meningitis with an SCH 39304-amphotericin B combination.

Authors:  M M Albert; J R Graybill; M G Rinaldi
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

7.  Comparative efficacy of amphotericin B colloidal dispersion and amphotericin B deoxycholate suspension in treatment of murine coccidioidomycosis.

Authors:  K V Clemons; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

8.  Pharmacokinetics, distribution in serum lipoproteins and tissues, and renal toxicities of amphotericin B and amphotericin B lipid complex in a hypercholesterolemic rabbit model: single-dose studies.

Authors:  K M Wasan; A L Kennedy; S M Cassidy; M Ramaswamy; L Holtorf; J W Chou; P H Pritchard
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

9.  Comparative efficacies of amphotericin B lipid complex and amphotericin B deoxycholate suspension against murine blastomycosis.

Authors:  K V Clemons; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

10.  Roles of liposome composition and temperature in distribution of amphotericin B in serum lipoproteins.

Authors:  K M Wasan; G A Brazeau; A Keyhani; A C Hayman; G Lopez-Berestein
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.